|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Thorac Cardiovasc Surg 2008;136:1105-1106
© 2008 The American Association for Thoracic Surgery
Letter to the Editor |
Associate Professor, Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania, Philadelphia, PA 19104-4283
To the Editor:
I read with great interest the excellent article by Halstead and colleagues1
detailing in their porcine model of deep hypothermic circulatory arrest (DHCA) the neuroprotective effects of selective cerebral perfusion (SCP) via both carotid arteries at a mean of 50 mm Hg for a period of 90 minutes. In this laboratory model, the authors have clearly demonstrated the adverse cerebral effects associated with SCP at higher pressures and flow rates. The clinical relevance of this observation is illustrated in the study by Khaladji and colleagues,2
in which they analyze outcomes after hypothermic circulatory arrest (71.1% hemiarch; 10.4% total arch) and bilateral cold selective SCP at a perfusion pressure of 40 to 60 mm Hg with flow rates of 400 to 650 mL/min.
However, Halstead and colleagues chose a long SCP time of 90 minutes, which is the time required for a total arch repair. In an earlier clinical study, these investigators3
demonstrated their technique with a trifurcated graft with mean DHCA/SCP times of 31.1 ± 6.6 minutes and 65.3 ± 20.9 minutes, respectively, with SCP perfusion pressures of 50 to 70 mm Hg with flow rates of 800 to 1200 mL/min. Hence, this latest laboratory study is part of their ongoing quest to optimize their technique of total arch replacement with SCP, and it suggests a new range for bilateral SCP perfusion pressures and flow rate.
However, although this model is clinically relevant for hemiarch repairs,2
how might it apply in the case of aortic arch repair with unilateral SCP?4
Would lower SCP perfusion pressures be clinically superior, assuming a clinically competent circle of Willis? Or would the contralateral brain be at significant risk of ischemia, given the relevant incidence of clinical inadequacy in the circle of Willis for cerebral perfusion in DHCA with unilateral SCP?5
Do the authors plan to evaluate unilateral SCP in their porcine DHCA model?
I congratulate the authors again on their important contribution. I look forward to their comments about these aspects of selective cerebral perfusion during adult aortic arch repair.
Footnotes
Financial support: Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |